142
A 4-month regimen of gatifloxacin with rifampin, isoniazid, and pyrazinamide is being evaluated for the treatment of tuberculosis in a phase 3 randomized controlled trial (OFLOTUB).
 gatifloxacin: Treatment; rifampin: Treatment; isoniazid: Treatment; pyrazinamide: Treatment; gatifloxacin: Treatment.Drug; rifampin: Treatment.Drug; isoniazid: Treatment.Drug; pyrazinamide: Treatment.Drug; tuberculosis: Treatment.Disorder; isoniazid: Combination.Drug; pyrazinamide: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 gatifloxacin: Treatment; rifampin: Treatment; isoniazid: Treatment; pyrazinamide: Treatment; gatifloxacin: Treatment.Drug; rifampin: Treatment.Drug; isoniazid: Treatment.Drug; pyrazinamide: Treatment.Drug; tuberculosis: Treatment.Disorder; isoniazid: Combination.Drug; pyrazinamide: Combination.Drug